Clinical Trial: Evaluating a Brief Virtual Cognitive Remediation Therapy Intervention for Those With Early Phase Psychosis and Substance Misuse

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056894) titled 'Evaluating a Brief Virtual Cognitive Remediation Therapy Intervention for Those With Early Phase Psychosis and Substance Misuse' on June 29.

Brief Summary: Psychotic disorders affect approximately 4.6 per 1000 people globally, translating to about 1.5 million Canadians. Despite their relatively low prevalence, these disorders have a significant impact due to their onset during youth and emerging adulthood, leading to substantial personal, family, and societal burdens. Economically, the direct costs for care exceed CAN$2 billion in Canada and $18 billion worldwide, with indirect costs such as lost productivity adding another CAN$4.8 ...